Mannosylated Chitosan Nanoparticles Based Macrophage-Targeting Gene Delivery System Enhanced Cellular Uptake and Improved Transfection Efficiency.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Nanoscience and Nanotechnology

• Publication date

  2015-04-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1166/JNN.2015.9252PMID 26353473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coaxially electrospun core/shell structured poly(L-lactide) acid/chitosan nanofibers for potential drug carrier in tissue engineering.

  2013cited by this paper
• Self-assembled phytosterol-fructose-chitosan nanoparticles as a carrier of anticancer drug.

  2013cited by this paper
• Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity.

  2013cited by this paper
• Evaluation of GABA-chitosan nanoparticle induced cell signaling activation during liver regeneration after partial hepatectomy.

  2012cited by this paper
• The effects of coating pDNA/chitosan complexes with chondroitin sulfate on physicochemical characteristics and cell transfection.

  2012cited by this paper
• Practical synthesis and characterization of mannose-modified chitosan.

  2012cited by this paper
• Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia.

  2012cited by this paper
• Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery

  2010cited by this paper
• Preparation, characterization and applications of low-molecular-weight alginate-oligochitosan nanocapsules.

  2010cited by this paper
• High entrapment efficiency of chitosan/polylactic acid/tripolyphotspate nanosized microcapsules for rapamycin by an emulsion-evaporation approach.

  2010cited by this paper
• Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting.

  2009cited by this paper
• Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.

  2009cited by this paper
• Low molecular weight chitosan in DNA vaccine delivery via mucosa.

  2009cited by this paper
• Vesicle Formation and Endocytosis: Function, Machinery, Mechanisms, and Modeling

  2009cited by this paper
• Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery.

  2008cited by this paper
• Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.

  2008cited by this paper
• Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.

  2008cited by this paper
• Chitosan-graft-polyethylenimine as a gene carrier.

  2007cited by this paper
• Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles.

  2006cited by this paper
• Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages.

  2006cited by this paper
• Gene Transfer by DNA/mannosylated Chitosan Complexes into Mouse Peritoneal Macrophages

  2006cited by this paper
• Lactosylated chitosan for DNA delivery into hepatocytes: the effect of lactosylation on the physicochemical properties and intracellular trafficking of pDNA/chitosan complexes.

  2006cited by this paper
• Mannosylated chitosan nanoparticle–based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells

  2006cited by this paper
• Characterization of folate-chitosan-DNA nanoparticles for gene therapy.

  2006cited by this paper
• Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.

  2004cited by this paper
• Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.

  2004cited by this paper
• Visualization of transfection of hepatocytes by galactosylated chitosan-graft-poly(ethylene glycol)/DNA complexes by confocal laser scanning microscopy.

  2003cited by this paper
• Mechanism of cell transfection with plasmid/chitosan complexes.

  2001cited by this paper
• Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines

  2000cited by this paper
• The macrophage – a novel system to deliver gene therapy to pathological hypoxia

  2000cited by this paper
• Mannose Polyethylenimine Conjugates for Targeted DNA Delivery into Dendritic Cells*

  1999cited by this paper
• DNA-polycation nanospheres as non-viral gene delivery vehicles.

  1998cited by this paper
• Gene therapy - promises, problems and prospects

  1997cited by this paper

• MANNosylation of Mesoporous Silica Nanoparticles Modifies TLR4 Localization and NF‐κB Translocation in T24 Bladder Cancer Cells

  2024cites this paper
• Biomimetic Systems Involving Macrophages and Their Potential for Targeted Drug Delivery

  2023cites this paper
• Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization

  2023cites this paper
• Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers.

  2022cites this paper
• Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs

  2021cites this paper
• Nanocarriers based oral lymphatic drug targeting: Strategic bioavailability enhancement approaches

  2021cites this paper
• Synergic treatment of Alzheimer’s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor

  2020cites this paper
• The biological challenges and pharmacological opportunities of 1

  2019cites this paper
• The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery

  2018cites this paper
• Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant

  2018cites this paper
• Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles

  2017cites this paper
• Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge

  2017cites this paper
• RNA Interference-Based Immunomodulation for Glioblastoma Immune Microenvironment: A Review

  2017cites this paper
• Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes

  2016cites this paper
• Micro- and nanoparticulates for DNA vaccine delivery

  2016cites this paper
• Chitosan-modified lipid nanovesicles for efficient systemic delivery of l-asparaginase.

  2016cites this paper
• Biodistribution of TAT-LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts.

  2016cites this paper
• Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses.

  2016cites this paper
• Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and amphotericin B against visceral leishmaniasis

  2016cites this paper
• Activation of Macrophages: Establishing a Role for Polysaccharides in Drug Delivery Strategies Envisaging Antibacterial Therapy.

  2015cites this paper
• Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines

  2015influential citation